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Introduction
Diabetes is a metabolic disorder resulting from defective 
insulin secretion, insulin action, or both. As a consequence, 
people with diabetes have chronically elevated plasma 
glucose levels and disturbances in metabolism that lead to 
complications such as retinopathy, neuropathy, nephropathy, 
and an increased risk of cardiovascular disease. Type 
2 diabetes, formerly known as non-insulin dependent 
diabetes mellitus, is due to relative, rather than absolute 
insulin deficiency and is characterised by a long period of 
hyperglycaemia that may last for years before symptoms 
appear (Laakso 2008). Obesity and lack of physical activity 
are major risk factors for the development of type 2 diabetes 
(Laakso 2008). In 1999/2000, an estimated 840 000 
Australians had type 2 diabetes with one undiagnosed case 
for every diagnosed case (AIHW 2008). Type 2 diabetes 
accounts for 83% of diagnosed diabetes and is responsible 
for about 5% of the total burden of disease in Australia 
(AIHW 2008).
Achieving and maintaining appropriate plasma glucose 
levels is vital to managing diabetes and this has traditionally 
been achieved using medication, dietary intervention and 
aerobic exercise (ADA 2008). The gold standard test to 
monitor long-term plasma glucose levels (over 2–3 months) 
is the monitoring of glycosylated haemoglobin (HbA1c). 
Diabetic interventions aim to achieve glycosylated 
haemoglobin levels of less than 7% in people with diabetes 
in order to reduce complications associated with diabetes 
(ADA 2008).
Muscle weakness, decreased muscle mass, and changes in 
skeletal muscle fibres are related to compromised glycaemic 
control in diabetes, possibly because of peripheral 
neuropathy and reduced vascular supply (Schuller and 
Linke 2008). Studies in animal models of diabetes have 
shown that resistance exercise can lead to increased muscle 
mass (Farrell et al 1999). Skeletal muscle is a large reservoir 
for glucose disposal in the body (Schuller and Linke 2008) 
and exercise is a powerful stimulant of glucose uptake 
partly through the action of the skeletal muscle glucose 
transporter protein (Schuller and Linke 2008). Therefore, 
resistance exercise with its direct effect on skeletal muscle 
may have a role in the management of patients with type 2 
diabetes.
According to the American College of Sports Medicine 
(2009), progressive resistance exercise is carried out 2–3 
times a week and consists of 1–3 sets of 8–12 repetitions, 
progressed from a load of 45–50% to 70–80% of 1RM, where 
1RM is the amount of weight that can be lifted just once 
through available range. Three previous systematic reviews 
have investigated both aerobic and resistance exercise and 
have provided evidence that exercise in general improves 
glycaemic control in people with type 2 diabetes (Boulé et al 
2001, Snowling and Hopkins 2006, Thomas et al 2006). The 
Boulé et al (2001) review included three trials of resistance 
exercise which were inconclusive, Snowling and Hopkins’ 
(2006) review included seven trials which produced a small 
benefit, and the Thomas et al (2006) review included three 
trials which were not analysed separately. No systematic 
review has focused on progressive resistance exercise alone 
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compared to other interventions, and included an evaluation 
of the safety of the intervention. Furthermore, new trials of 
resistance exercise have been published since 2006.
Therefore, the specific research questions for this review 
were:
Does progressive resistance exercise improve 1. 
glycaemic control in people with type 2 diabetes more 
than aerobic or no exercise?
Does it improve strength and body composition?2. 
Is it safe?3. 
Method
Identification and selection of studies
Relevant randomised trials were identified using a predefined 
search strategy (see Appendix 1 on the eAddenda for 
full search strategy) to search three databases: CINAHL, 
MEDLINE, and EMBASE. These electronic databases 
were searched from the earliest date available until July 
2008. Manual searches of reference lists were conducted to 
ensure all relevant studies were captured. Two reviewers (CI 
and NT) independently applied the inclusion and exclusion 
criteria (Box 1) to the titles and abstracts of all the studies 
retrieved and any that clearly did not fulfil the criteria were 
eliminated. Where it was not clear, the full text papers of 
the studies were obtained for review. The trials had to be 
randomised trials comparing progressive resistance exercise 
to a suitable control group (eg, aerobic exercise, flexibility 
training, or sedentary) of participants with type 2 diabetes 
mellitus. Trials that included combined or mixed training 
(where progressive resistance exercise was completed in 
combination with aerobic exercise) were excluded in order to 
focus on the effects of progressive resistance exercise alone. 
Trials should have described the diagnostic criteria for type 
2 diabetes. Acceptable definitions include the World Health 
Organisation and the American Diabetes Association’s 
criteria of fasting plasma glucose ≥ 7.0 mmol/l (WHO/IDF 
2006). Only trials of greater than eight weeks’ duration 
were included since periods shorter than this are unsuitable 
to show changes in glycosylated haemoglobin. Trials were 
excluded if the participants had other conditions such as 
type 1 diabetes mellitus, gestational diabetes, or impaired 
glucose tolerance, or if the intervention was another form of 
exercise or mixed training. Where results were duplicated 
in more than one paper the original paper was chosen for 
inclusion.
Assessment of characteristics of studies
Quality: All trials were critically appraised for 
methodological quality using the PEDro scale (www.pedro.
org.au) by two authors independently (CI and NT). Trials 
were not excluded on the basis of quality; however, quality 
was taken into account when interpreting results.
Participants: Age, BMI, and baseline % HbA1c levels were 
recorded in order to compare the similarity of participants 
between trials.
Intervention: The target muscles, intensity, and duration 
of intervention were recorded. The control groups were 
categorised as non-exercise or aerobic training. For the 
purposes of this review, flexibility training was categorised 
as non-exercise since it has negligible energy expenditure 
and is therefore unlikely to have an effect on glycaemic 
control.
Outcome measures: The primary outcome was glycaemic 
control measured as percentage glycosylated haemoglobin 
(HbA1c). Secondary outcomes were body composition (lean 
body mass and fat free mass), strength (% change in 1RM, 
dynamometry), and adverse events. Where results for upper 
and lower limb muscles were presented, the lower limb 
results were used, since the lower limbs would be expected 
to provide a larger reservoir for glucose disposal than the 
upper limbs and so be more relevant for people with type 
2 diabetes. Where both sides were measured, the left side 
was chosen.
Data analysis: Data were extracted and entered onto a 
customised form to record baseline characteristics, details of 
intervention and control groups, adverse events, and primary 
and secondary outcomes. Where sufficient information was 
obtained, standardised mean differences (effect sizes) were 
calculated for the outcomes based on post intervention 
means and the pooled estimate of post exercise standard 
deviations, using Hedges g. Meta-analyses were performed 
using a random effects model for primary and secondary 
outcomes using inverse variance methods (RevMan 2008). 
Statistical heterogeneity was assessed using I2 statistic with 
values of less than 25% assigned as representing low levels 
of heterogeneity (Higgins et al 2003). The strength of the 
standardised mean difference was determined descriptively 
according to Cohen et al (1962), where 0.2 is considered 
small, 0.5 moderate, and 0.8 large. Where standard errors 
were provided they were converted to standard deviations. 
Authors were contacted for further information where 
required.
To calculate the between group percentage difference in 
HbA1c a meta-analysis on mean differences was performed 
using a random effects model and inverse variance methods 
(RevMan 2008). Analysis was performed separately for 
results of trials that compared progressive resistance exercise 
with a non-exercising control and those that compared 
progressive resistance exercise with aerobic exercise.
Box 1. Inclusion criteria.
Design
Randomised trials• 
Full peer-reviewed papers• 
Participants
Type 2 diabetes mellitus (as defined by WHO 2006, • 
ADA 2008)
Human• 
Intervention
Progressive resistance exercise (as defined by • 
ACSM 2009)
Exercise > 8 weeks duration• 
Outcome measures
Glycaemic control as measured by glycosylated • 
haemoglobin (HbA1c)
Comparisons
Progressive resistance exercise versus no exercise• 
Progressive resistance exercise versus aerobic • 
exercise
WHO = World Health Organisation, ADA = American Diabetes 
Association, ACSM = American College of Sports Medicine
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Results
Flow of studies through the review
The search yielded a total of 449 studies. A manual search 
of reference lists did not yield any more trials. From the 
titles and abstracts, 429 studies clearly did not fulfil the 
criteria or existed in more than one database and were 
eliminated. Full text copies of 20 studies were obtained 
for further examination. Eleven of these were excluded 
because: duplicate data existed in four articles (Brooks et 
al 2007, Daly et al 2005, Dunstan et al 2005, Gordon et 
al 2006), four were not randomised trials (De Fayter et al 
2007, Ibanez et al 2005, Ishii et al 1998, Lomangino et al 
2005), two did not investigate glycaemic control (Brandon et 
al 2003, Castaneda et al 2006), and one involved combined 
exercise (Cuff et al 2003). Consensus was reached to yield a 
total of nine relevant trials (Figure 1).
Characteristics of included studies
Quality: The methodological quality of the studies sourced 
was low to moderate with a mean PEDro score of 5.0 out 
of 10 (SD 1.6) (Table 1). Quality scores ranged from 3 
(Cauza et al 2005b) to 8 (Sigal et al 2007). No trials blinded 
participants or therapists. Since blinding of participants and 
therapists is not feasible with an intervention of progressive 
resistance exercise the highest expected score was 8. Only 
one trial had blinded assessors (Sigal et al 2007) and this 
was the only trial with concealed allocation of participants. 
Six out of nine trials had 85% retention rates and all trials 
reported point measures and measures of variability.
Participants: The review included 372 participants, of 
whom 192 completed progressive resistance exercise. 
Participants were males (66%) and females with a weighted 
mean average age of 58.4 years ranging between 46.5 
(Baldi and Snowling 2003) and 67.6 years (Dunstan et al 
2002). Most participants were overweight or obese with a 
Figure 1. Flow of studies through the review.
Titles and abstracts screened (n = 449)
Papers excluded after screening 
titles/abstracts (n = 429)
Papers excluded after evaluation  
of full text (n = 11)
Duplicate data (n = 4)• 
Not RCT (n = 4)• 
Not investigating glycaemic  • 
control (n = 2)
Combined intervention (n = 1)• 
Potentially relevant papers retrieved for 
evaluation of full text (n = 20)
Papers included in review (n = 9)
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weighted mean body mass index of 32.0 kg/m2. Duration 
of diabetes ranged from a mean of 4.8 (Dunstan et al 1998) 
to 9.0 years (Cauza et al 2005a) with a weighted average 
duration of 7.2 years. Participants had a weighted average 
baseline HbA1c of 7.9% (SD 1.4) representing a slightly 
elevated level of HbA1c (Table 2). Cauza et al (2005a and b) 
were contacted and confirmed that the two trials involved 
different participants.
Intervention: All interventions occurred on three non-
consecutive week days with the exception of one in which 
exercise occurred twice per week (Honkola et al 1997). 
Exercise was supervised in research centres or community 
settings utilising free weights or weight machines. 
Supervision was provided by physiotherapists, research 
assistants, nurses, or personal trainers. Interventions ran 
for a weighted average of 19.8 weeks, ranging from 8 
weeks (Dunstan et al 1998) to 26 weeks (Sigal et al 2007). 
Sessions typically lasted 45–50 minutes and consisted of 
2–3 sets (with the exception of Cauza et al 2005a and b 
where 1–2 sets were completed) of 8–15 repetitions of 5–10 
exercises. All trials increased the intensity of training over 
the duration of the intervention. Different methods were 
used to progress training. Three trials based progression 
on 1RM tested at baseline and mid-study (Castaneda et 
al 2002, Dunstan et al 1998, Dunstan et al 2002), others 
progressed by increasing sets (Baldi and Snowling 2003, 
Baum et al 2007), or increasing resistance systematically 
when targets were reached (Cauza et al 2005a and b, Sigal 
et al 2007), and in one trial the method of progression was 
not detailed (Honkola et al 1997). The weighted average rate 
of adherence to progressive resistance exercise was 87% of 
scheduled sessions.
Outcome measures: All measurements of strength were 
of maximum voluntary force production by dynamometry 
or maximum weight moved (1RM). Three trials measured 
quadriceps strength, one measured the bench press, one 
measured both bench press and leg press, one measured 
strength of the upper and lower limb exercises, and one 
presented results as the sum of scores. The remaining two 
trials did not assess strength (Honkola et al 1997, Sigal 
et al 2007). Lean body mass was measured by dual x-ray 
absorbiometry (Castaneda et al 2002, Dunstan et al 2002) 
or calculated from skin fold measurements (Cauza et al 
2005a and b). Fat-free mass was calculated by densitometry 
through hydrostatic weighing (Baldi and Snowling 2003) 
and bioelectrical impedance analysis (Sigal et al 2007). 
Baum et al (2007) was contacted and confirmed that 
measures of dispersion of HbA1c values were represented 
as standard deviations and not standard errors.
Effect of progressive resistance exercise
Glycosylated haemoglobin: When compared with non-
exercising controls in seven trials, progressive resistance 
exercise lowered HbA1c by a small but significant amount 
(SMD –0.25, 95% CI –0.47 to –0.03) (Figure 2a, see also 
Figure 3a on the eAddenda for detailed forest plot). The 
absolute reduction of HbA1c was 0.3% (95% CI 0.0 to 0.6, 
I2 0%) with Baum et al (2007) excluded, and 0.1% (95% CI 
–0.1 to 0.30, I2 8%) with Baum et al (2007) included, with 
only 26 participants accounting for 62% of the weight (due 
to the very small standard deviations).
When compared with aerobic exercise in three trials, 
progressive resistance exercise had no significant effect on 
HbA1c (SMD –0.04, 95% CI –0.38 to 0.30, I2 13%) (Figure 
2b, see also Figure 3b on the eAddenda for detailed forest 
plot).
Strength: One trial that tested strength did not present 
post intervention strength data so was not included in the 
analyses (Dunstan et al 1998). When compared with non-
exercising controls in four trials, progressive resistance 
exercise resulted in a large and significant increase in muscle 
strength (SMD 0.95, 95% CI 0.58 to 1.31, I2 34%) (Figure 
4a, see also Figure 5a on the eAddenda for detailed forest 
plot). This was equivalent to a weighted average increase in 
muscle strength of 35%.
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Figure 2. SMD (95% CI) of effect of progressive resistance 
exercise on HbA1c compared with a) no exercise by pooling data 
from 7 studies (n = 321), and b) aerobic exercise by pooling data 
from 3 studies (n = 178).
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Figure 4. SMD (95% CI) of effect of progressive resistance 
exercise on muscle strength compared with a) no exercise by 
pooling data from 4 studies (n = 135), and b) aerobic exercise by 
pooling data from 2 studies (n = 44).
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When compared with aerobic exercise in two trials, 
progressive resistance exercise resulted in a very large and 
significant increase in muscle strength (SMD 1.44, 95% CI 
0.83 to 2.05, I2 0%) (Figure 4b, see also Figure 5b on the 
eAddenda for detailed forest plot).
Body composition: When compared with non-exercising 
controls in 4 trials, progressive resistance exercise had no 
significant effect on body composition (SMD 0.13, 95% CI 
–0.14 to 0.40, I2 5%) (Figure 6a, see also Figure 7a on the 
eAddenda for detailed forest plot).
When compared with aerobic exercise in 3 trials, 
progressive resistance exercise had no significant effect on 
body composition (SMD –0.08, 95% CI –0.37 to 0.22, I2 
0%) (Figure 6b, see also Figure 7b on the eAddenda for 
detailed forest plot.)
Irvine and Taylor: Progressive resistance exercise in diabetes
A 1% decrease in glycosylated haemoglobin is associated 
with a 37% decrease in the risk for microvascular 
complications and a 21% decrease in the risk of death 
associated with diabetes (Stratton et al 2000). The United 
Kingdom Prospective Diabetes Study concluded that 
any reduction in glycosylated haemoglobin is clinically 
significant as it is likely to reduce the risk of diabetic 
complications (Stratton et al 2000). One way of interpreting 
the results of this review is that participants who completed 
progressive resistance exercise made a 55% improvement 
towards the target value of glycosylated haemoglobin of 
7.0% (where their glycosylated haemoglobin reduced by 
0.5%, from 7.9% to 7.4%, during the intervention). It has long 
been recommended that the three cornerstones of diabetic 
therapy are medication, diet, and exercise (ADA 2008). 
Oral hypoglycaemic medications can reduce glycosylated 
haemoglobin by 0.5% to 2% (Willett et al 2004). These 
medications can be costly and are commonly associated 
with gastrointestinal side-effects (flatulence, nausea, 
diarrhoea, and abdominal pain) and weight gain (Willett 
et al 2004). Their efficacy also declines over time by 0.2% 
to 0.3% each year (Horan et al 2006). Dietary management 
including low GI, individualised meal plans and medical 
nutrition therapy can reduce glycosylated haemoglobin by 
0.43% to 1% in people with established diabetes and is more 
effective in newly diagnosed people (Horan et al 2006). 
Therefore, compared with no exercise control groups, the 
overall absolute reduction of glycosylated haemoglobin of 
0.3% found in this systematic review is small, suggesting 
that progressive resistance exercise should not be a stand-
alone treatment for people with type 2 diabetes. However, the 
positive effect indicates that progressive resistance exercise 
may be part of a management plan, in combination with 
medication and an appropriate diet, to produce clinically 
significant reductions in complications associated with type 
2 diabetes.
Snowling and Hopkins (2006) in their review reported 
a 0.5% decrease in glycosylated haemoglobin following 
progressive resistance exercise. The slight observed 
difference in results may be due to poorer quality trials in 
that review, the inclusion of trials of less than eight weeks 
duration and the smaller number of trials. The current review 
has also included a large trial of good quality which should 
be less subject to bias (Sigal et al 2007). Thomas et al (2006) 
reported a 0.6% decrease in glycosylated haemoglobin 
following exercise. Trials with combined training (both 
aerobic and resistance) were included in the Thomas review 
and may have an additive effect on results. The nine trials in 
the current review included trials of variable study quality 
ranging from a PEDro score of three to eight. The two trials 
that rated highest in trial quality (Castenada et al 2002, Sigal 
et al 2007) reported results similar to the meta-analysis. 
For the comparison of progressive resistance exercise with 
a no exercise control group, Castenada et al (2002) and 
Sigal et al (2007) reported standardised mean differences 
in glycosylated haemoglobin of 0.32 and 0.22, respectively, 
compared with the value of 0.25 from the meta analysis in 
the current review. This suggests that the meta-analysis was 
not over-estimated due to influence of trials of lesser quality 
that would have been more subject to bias. Castenada et al 
(2002) and Sigal et al (2007) were also the two trials with 
the highest sample sizes, with well-described high intensity 
progressive resistance exercise interventions lasting from 
16 to 26 weeks, suggesting that they also rated highly in the 
quality of the intervention as well as in quality of the study 
methods (Herbert and Bo 2005).
Safety: The presence or absence of adverse events was 
recorded in eight of the nine trials. Seven of these stated 
there were no exercise-related injuries or serious adverse 
events. The eighth trial, Cauza et al (2005a), reported there 
was no difference between the frequency of hyperglycaemic 
episodes in the progressive resistance exercise group 
compared with the aerobic exercise group. The most 
commonly reported problem was delayed onset muscle 
soreness.
Discussion
The results of this systematic review provide evidence from 
nine randomised trials involving 372 participants with type 
2 diabetes that progressive resistance exercise improves 
glycaemic control by lowering glycosylated haemoglobin. 
In addition progressive resistance exercise leads to large 
increases in muscle strength for people with type 2 
diabetes.
Figure 6. SMD (95% CI) of effect of progressive resistance 
exercise on body composition compared with a) no exercise by 
pooling data from 4 studies (n = 236), and b) aerobic exercise  
by pooling data from 3 studies (n = 178).
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The results of the current systematic review show that 
progressive resistance exercise is significantly better than 
not exercising in reducing glycosylated haemoglobin to 
improve glycaemic control but it is not significantly better 
than aerobic exercise in achieving these improvements. 
This trend has been demonstrated before in a summary of 
systematic reviews on exercise by Taylor et al (2007). The 
authors found that across a broad range of musculoskeletal, 
cardiorespiratory, and neurological conditions exercise 
was better than not exercising; however, there was a lack 
of evidence to suggest that one type of exercise was better 
than another. One interpretation is that the choice of 
exercise for people with type 2 diabetes may be decided 
upon according to co-morbidities, personal preference, 
available resources, and a need for variety whilst knowing 
that progressive resistance exercise is a viable alternative to 
aerobic exercise.
Due to the small number and the mild nature of adverse 
events reported in the reviewed trials, progressive resistance 
exercise appears to be a relatively safe form of exercise for 
people with type 2 diabetes. Pollock et al (1991) established 
that there were twice as many complications during 
jogging and walking exercises when compared to strength 
training in older adults. Low rates of adverse events were 
also noted in a systematic review of progressive resistance 
exercise in community-dwelling older adults (Dodd et al 
2002). Importantly, the participants in our review were 
overweight and previously sedentary, making it noteworthy 
that there were so few adverse events. However, it should 
also be considered that as reporting of adverse events was 
inconsistent and, as serious adverse events are rare, the 
sample sizes may have been too small to have detected 
serious adverse effects.
Complying with aerobic exercise recommendations can be 
challenging. Aerobic exercise needs to be completed on 
most, if not all, days of the week to be effective. The current 
review provides evidence that progressive resistance exercise 
can be effective when performed only three times a week 
and that compliance rates are high with 87% of scheduled 
sessions attended. Even walking may be difficult or risky 
because of co morbidities such as arthritis, cardiovascular 
disease, peripheral vascular disease, neuropathy, and 
mobility impairments. Progressive resistance exercise may 
be preferred by some older people with complications of 
diabetes. These include foot ulceration, Charcot’s joint, 
amputations without prosthesis, angina, claudication, and 
people at risk of falls. In all these situations resistance 
exercise is not only a viable alternative, but it may also be 
more feasible than aerobic exercise.
For those who can participate safely in aerobic exercise, 
another option to consider is whether a combined exercise 
program is more beneficial than doing progressive resistance 
exercise program alone. Sigal et al (2007) reported that 
glycosylated haemoglobin values reduced significantly 
more in the combined exercise training group than in the 
aerobic or resistance exercise alone groups. However, the 
review of Snowling and Hopkins (2006) did not detect any 
significant additional benefits of combined training.
The results show that participants got stronger during the 
intervention but did not increase their lean body mass or fat 
free mass suggesting that the muscles became more efficient 
at glucose disposal without changing their morphology 
through hypertrophy. It is possible that measurement error 
in the methods of measuring body composition may have 
obscured any true effects. However, the densitometry, 
dual X-ray absorptiometry and bioelectrical impedance 
techniques used in four of the six trials have demonstrated 
high precision in the measurement of body composition 
(Woodrow 2009). The two trials that estimated body 
composition based on skin fold measures (Cauza et al 2005a 
and b) may have had a limited ability to detect change 
(Woodrow 2009), although these trials only compared 
progressive resistance exercise to aerobic training, and so 
did not affect the meta-analysis comparing the intervention 
with no intervention. This leads to the question of whether 
longer trials that could influence muscle morphology 
might have a larger effect on glycaemic control, or whether 
participants trained with sufficient intensity to provide a 
stimulus to produce changes in muscle morphology. Since 
the average program ran for nearly 20 weeks, it appears 
that program length was sufficient. Ensuring adherence to 
protocol intensity for progressive resistance exercise, and 
ensuring frequent progression of the training intensity (as 
participants are starting from a low baseline of strength) 
may have the potential to further benefit glucose control.
A strength of this review is that it follows the QUOROM 
checklist for high quality reporting of systematic reviews 
(Moher et al 1999). It includes all recent and relevant 
trials, and an evaluation of adverse events. The results are 
clinically applicable since the included participants are 
typical of the diabetic population; higher risk with obesity, 
occurs most commonly in people over 40 years of age, 
with higher prevalence rates for males (AIHW 2008). The 
interventions are replicable as they were held in common, 
low-cost settings with readily available equipment, and 
were supervised by physiotherapists or other appropriately 
trained professionals.
A limitation of this review is that its conclusions rely on the 
quality of the included trials, where only three scored higher 
than four on the quality assessment scale. Good quality 
trials are less likely to be subject to bias and give the most 
accurate estimate of the effect of the intervention. Another 
limitation was that relevant data were not reported, or were 
only represented diagrammatically in some of the trials. For 
example, measures of strength in Baum et al (2007) were 
estimated from a figure. There was also a lack of long-term 
follow-up in the trials. Another limitation is that the meta-
analysis of mean difference in percentage glycosylated 
haemoglobin may have been biased by the inclusion of a 
trial with very small standard deviations (Baum et al 2007), 
leading to this relatively small trial contributing more than 
60% weight to the overall estimate of 0.1% glycosylated 
haemoglobin. We decided to complete a sensitivity analysis 
excluding this trial which resulted in a value of 0.3% 
glycosylated haemoglobin. This value was interpreted as 
more likely to reflect the true mean difference, as it was 
similar to the value reported in the largest high quality trial 
included in the review (Sigal et al 2007).
In conclusion, this systematic review has demonstrated that 
progressive resistance exercise leads to small but statistically 
significant improvements in glycosylated haemoglobin and 
therefore glycaemic control. The results are likely to be 
clinically significant since any improvement in glycaemic 
control that can be achieved safely is considered important. 
Eight weeks with two-three sessions of 45 minutes duration 
of progressive resistance exercise is sufficient to produce 
improvements in glycaemic control. Future research should 
focus on making progressive resistance exercise more 
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achievable and cost-effective by assessing the minimum 
duration of the program, minimum frequency of sessions 
and minimum duration of each session required to produce 
the desired benefits. Research should also address the 
possible additive benefits of combined aerobic and resistance 
exercise on glycosylated haemoglobin. Long-term trials 
would also be beneficial to determine how best to maintain 
these improvements in glycaemic control. Progressive 
resistance exercise is a feasible option to include in the 
management of glycaemic control for people with type 2 
diabetes mellitus. n
eAddenda: Appendix 1 Search strategy, and Appendix 2 
Figures 3, 5, and 7, available at AJP.physiotherapy.asn.au
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